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Bacterial exopolysaccharides
Polysaccharides are polymers of carbohydrates with an
enormous structural diversity, from long linear repetition of
the same monomer to highly branched structures of dif-
ferent sugars. This high structural diversity reflects the
functional diversity of these molecules. There are two
types of polysaccharides, storage polysaccharides (i.e.
glycogen) and structural polysaccharides, which are nor-
mally secreted by the cell and form different cell structures
(i.e. cellulose, chitin). Extracellular polysaccharides or
exopolysaccharides belong to this last group.
Exopolysaccharides are produced not only by microor-
ganisms, but also by algae, plants and animals (Suther-
land, 2005). Bacterial exopolysaccharides are a major
component of the extracellular polymeric substance
(EPS) or matrix of biofilms, and mediate most of the
cell-to-cell and cell-to-surface interactions required for
biofilm formation and stabilization (Flemming and Win-
gender, 2010). The matrices of biofilms from natural envi-
ronments, such as marine and fresh water, soil, or chronic
infections, contain a ubiquitous composition of polysac-
charides. More than 30 different matrix polysaccharides
have been characterized so far. Several are homopoly-
saccharides (i.e. glucans, fructans, cellulose), but most of
these are heteropolysaccharides consisting on a mixture
of sugar residues. Exopolysaccharides can even differ
between strains of single species, as exemplified by
strains of Pseudomonas aeruginosa, which can produce
one, two or three different exopolysaccharides (alginate,
Pel and Psl) (Ryder et al., 2007). Since most mutants
deficient in the synthesis of exopolysaccharides are
impaired for biofilm formation it was assumed that bacte-
rial exopolysaccharides play only a structural role in bio-
films (Sutherland, 2001). However, in recent years an
unexpected function for these molecules as inhibitors of
biofilm formation has been described. This new function
has been thoroughly reviewed by Rendueles and col-
leagues in a recent issue of Environmental Microbiology
(2012).
Polysaccharides with the ability to inhibit and/or desta-
bilize biofilm formation are referred to as antibiofilm
polysaccharides, and their production appears to be a
well-conserved ability among living organisms. Interest-
ingly, antibiofilm polysaccharides do not have biocidal
activity, a property that could increase the technological
applications of these molecules as antibiofilm agents in
industry and medicine by diminishing the emergence of
resistance by natural selection.
Antibiofilm polysaccharides
The first bacterial polysaccharide with antibiofilm activity
was identified in an uropathogenic Escherichia coli strain.
This bacterium contains a group II capsular polysaccha-
ride able to inhibit biofilm formation by several bacteria,
including commensal E. coli strains, P. aeruginosa, Kleb-
siella pneumoniae, Staphylococcus and Enterococcus
(Valle et al., 2006). Since then, an increasing number of
antibiofilm polysaccharides from several bacterial species
encountered in many different environments have been
discovered (Rendueles et al., 2012). Most of these anti-
biofilm agents are able to inhibit the biofilm formation of a
broad range of bacteria, suggesting that they may play an
essential role in microbial competition and niche exclu-
sion. However, several antibiofilm exopolysaccharides
also inhibit the biofilm formation of the producer strain in
an auto-regulatory process to control biofilm architecture
(Bendaoud et al., 2011). Of special interest are the Psl
and Pel exopolysaccharides of P. aeruginosa that are
capable of carrying out antagonistic functions. These mol-
ecules inhibit biofilm formation of the competitors (i.e.
Staphylococcus epidermidis) (Qin et al., 2009), while at
the same time boosting that of the producer strain (Colvin
et al., 2011).
Polysaccharides with antibiofilm activity are also pro-
duced by eukaryotes (Rendueles et al., 2012). The first
one described was furonan, a polysaccharide produced
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by the seaweed Gloipeltis furcata that inhibits biofilm for-
mation of several oral bacteria and is able to prevent
plaque formation when administrated as chewing gum
(Sato et al., 1998). Several polysaccharides isolated from
plants (i.e. okra fruit, Aloe vera, licorice root, ginseng,
blackcurrant) have been shown to be able to inhibit the
binding of Helicobacter pylori, among other bacteria, to
human gastric cells (Rendueles et al., 2012).
Although the mode of action of antibiofilm polysaccha-
rides is not completely known yet, none of the compounds
identified to date exhibits biocidal activity. This indicates
that the antibiofilm activity of these polysaccharides is
mediated through different mechanisms. Most evidence
suggests that these molecules act by modifying the physi-
cal properties of both abiotic and biotic (i.e. bacterial cell)
surfaces (Rendueles et al., 2012). For example, E. coli
exopolysaccharides can increase the hydrophilicity
of glass surfaces, and can also inhibit the autoaggrega-
tion via adhesins of bacterial cells (Valle et al., 2006;
Rendueles et al., 2011). Polysaccharides, as sugar poly-
mers, have also the capacity to act as lectin inhibitors.
Lectins are proteins that specifically recognize and bind
sugars without modifying these molecules. In bacteria, the
primary function of lectins is to facilitate attachment or
adherence of bacteria to host cells. These proteins play
an important role in biofilm formation, and are essential for
bacterial colonization and infection. Lectins are mainly
located on the surface of bacteria cells where they can
access and bind to the glycan substrates present on
the surface of host cells (Esko and Sharon, 2009). By
competing for the sugar binding domain of lectins,
polysaccharides can inhibit lectin-dependent adhesion of
pathogens and biofilm formation. In fact, several plant,
microbial and milk polysaccharides have been shown to
block various lectins from human pathogenic bacteria by
competitive inhibition (Zinger-Yosovich and Gilboa-
Garber, 2009; Zinger-Yosovich et al., 2010).
Nevertheless, some studies also suggest that exopoly-
saccharides can act as signalling molecules to regulate
gene expression. Microarray analyses have shown that
the Lactobacillus acidophilus A4 polysaccharide down-
regulated the expression of E. coli genes involved in
biofilm formation (Kim et al., 2009). Interestingly, the syn-
thesis of the extracellular cellulosome complex of Clostrid-
ium thermocellum, which is required for hydrolysis of the
plant cell wall by the bacterium, is regulated by the pres-
ence of exopolysaccharides via alternative sigma factors
(Nataf et al., 2010). Exopolysaccharides are recognized
by the extracellular carbohydrate-active module of a
transmembrane anti-sigma factor. Binding of the exopoly-
saccharide to the anti-sigma factor results in the activation
of its cognate alternative sigma factor, which then inter-
acts with the RNA polymerase and initiates transcription
of the cellulosomal synthetic operon. Identification and
characterization of more of such regulatory proteins
containing both polysaccharide binding and regulatory
domains will help to unravel the molecular mechanism
behind the antibiofilm activity of exopolysaccharides.
Biotechnological applications
Biofilm formation represents the prevailing microbial life-
style in natural environments and occurs on all surface
types, including places where humans do not want them.
Since biofilms interfere with the action of several antibiot-
ics and bacterial drugs, biofilm-forming bacteria are more
difficult to eradicate (Costerton et al., 1999). In hospitals,
an environment markedly susceptible to contamination by
bacterial pathogens, biofilms are a particularly important
problem. Medical devices, such as catheters, heart
valves, prostheses, surgical pins, etc., can be colonized
by bacterial biofilms and become sources of infections
(Davies, 2003). Moreover, many chronic infections, like
diabetic ulcers or lung infections in patients with cystic
fibrosis, result from bacteria growing as biofilms (Coster-
ton et al., 1999). Bacterial biofilms are also very problem-
atic in industrial settings. The presence of biofilms is
common in for example the food industry and, because
several foodborne bacteria are human pathogens, it is
considered a serious public health risk. Moreover, biofilms
cause several other problems in industry, like mechanical
blockages and impedance of heat transfer processes,
shortening the lifetimes of modules in fermentors, and
increase the corrosion rate of surfaces (Kumar and
Anand, 1998). Consequently, the use of bacterial mutant
strains that present a deficiency in biofilm formation have
been shown to enhance biotechnological processes
(Sung et al., 2006). However, there is still a clear unmet
need for controlling bacterial biofilms. Antibiofilm polysac-
charides represent a promising alternative to battle biofilm
formation and bacterial infections. These molecules
combine two important characteristics: they are able to
block biofilm formation and do not have biocidal activity,
which may prevent the emergence of resistance to a great
extent. Furthermore, antibiofilm polysaccharides have
other important features, such as biocompatibility, biode-
gradability and non-toxicity, which increase their potential
to be used in medical and industrial applications. Addition-
ally, exopolysaccaharides act on a wide range of bacterial
strains, so can be useful for the treatment of multispecies
infection, and some of them are able to disrupt preformed
biofilms. As described by Rendueles and colleagues in
their recent review (2012), antibiofilm polysaccharides
could be co-administered with common antibiotics, as
they would disaggregate the biofilm facilitating the access
of the antibiotics. Moreover, exopolysaccharides are
surfactant molecules that alter the physico-chemical
properties of surfaces and could be therefore used as
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anti-adhesive coating for medical devices. Additionally,
since some polysaccharides and oligosaccharides inhibit
attachment of bacteria to human gastric cells, they could
be used as probiotics. In fact, plant and microbial polysac-
charides are already being widely used in the food indus-
try as emulsifiers and stabilizers (i.e. the food additive
guar gum also known as E412).
Nowadays, an estimated 20% of all bacterial exopoly-
saccharides are known (Rendueles et al., 2012).
However, the ongoing development of new and potent
high-throughput technologies will allow the discovery of a
large number of new compounds, including new antibio-
film exopolysaccharides. For instance the recently devel-
oped nanoDESI platform allows the direct sampling of
extracellular compounds from almost any surface, includ-
ing bacterial colonies, plants, and animals (Watrous et al.,
2012). This new approach applies rapid and highly sensi-
tive mass spectrometry (MS) to directly monitor and char-
acterize secreted molecules produced from live cells. This
powerful technology is able to detect and characterize
compounds that could not be identified by traditional bio-
chemical approaches. The use of this technology opens
an important new field of research that will allow the
discovery of many new natural products, which in turn
will have important biotechnological implications. Glycan
arrays are another example of a new high-throughput
technology that will lead to the discovery of new antibiofilm
compounds. This technology enables a high-sensitivity
and high-throughput analysis of carbohydrate–protein
interactions. Several platforms have been created in which
hundreds of glycan molecules (including polysaccharides)
are covalently or non-covalently immobilized to a surface
(i.e. glass, polystyrene, aluminium, silicon) (Liang and Wu,
2009). Using fluorescence-based measurements (among
others), polysaccharides capable of attaching to for
example bacterial adhesins (i.e. lectins) can be directly
detected. Once identified, the carbohydrate-based inhibi-
tor can be used to prevent lectin binding to its receptor.
Glycoarrays are in fact becoming a priceless tool for the
discovery of new biofilm inhibitors that target bacterial
adhesins (Blanchard et al., 2008).
Antibiofilm agents have been considered a promising
strategy for the development of novel therapeutics for the
control of bacterial proliferation for a long time. However,
despite the increasing knowledge on biofilms, no antibio-
film products are on the market yet. As recently discussed
by Romero and Kolter (2011), the main reasons for this
may be economic rather than scientific. Nevertheless,
continued research efforts in this area lead to the identi-
fication of new strategies that may be translated into prod-
ucts in the future. Antibiofilm exopolysaccharides are one
of these newly identified strategies that, given the years of
successful use of other polysaccharides (Sutherland,
1998), may have a promising future in the market.
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